{"title":"Neutrophils from Protection to Pathogenesis in Tuberculosis.","authors":"Hussain Beig, Amit Singh","doi":"10.1021/acsinfecdis.5c00096","DOIUrl":null,"url":null,"abstract":"<p><p><i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), the etiological agent of tuberculosis (TB), is well-equipped to establish infection, endure host immune pressures, and propagate to naïve individuals; its success depends on its ability to actively evade and recalibrate the host immune system. The balance between immunological control and bacterial persistence often shapes the clinical outcome of an <i>Mtb</i> infection. While the roles of macrophages and T cells have been extensively characterized in this balance, the contribution of neutrophils remains comparatively underexplored. The abundance of neutrophils in TB granulomas and their correlation with disease severity in humans and animal models suggest a vital role for these immune cells in TB infection. This review summarizes our current understanding of neutrophils in TB pathogenesis at different scales and models─in vitro, ex vivo, and in vivo─while highlighting some of the outstanding questions at each level. We delve into emerging concepts in neutrophil biology, including heterogeneity, metabolism, and maturation, along with <i>Mtb</i>'s mechanisms to modulate and evade neutrophil bactericidal stresses to ensure its persistence. A deeper understanding of neutrophil biology and the interaction with <i>Mtb</i> could inform the development of more effective therapies and diagnostic strategies against TB.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.5c00096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), is well-equipped to establish infection, endure host immune pressures, and propagate to naïve individuals; its success depends on its ability to actively evade and recalibrate the host immune system. The balance between immunological control and bacterial persistence often shapes the clinical outcome of an Mtb infection. While the roles of macrophages and T cells have been extensively characterized in this balance, the contribution of neutrophils remains comparatively underexplored. The abundance of neutrophils in TB granulomas and their correlation with disease severity in humans and animal models suggest a vital role for these immune cells in TB infection. This review summarizes our current understanding of neutrophils in TB pathogenesis at different scales and models─in vitro, ex vivo, and in vivo─while highlighting some of the outstanding questions at each level. We delve into emerging concepts in neutrophil biology, including heterogeneity, metabolism, and maturation, along with Mtb's mechanisms to modulate and evade neutrophil bactericidal stresses to ensure its persistence. A deeper understanding of neutrophil biology and the interaction with Mtb could inform the development of more effective therapies and diagnostic strategies against TB.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.